Article Text

Download PDFPDF
TBI—the most complex disease in the most complex organ: the CENTER-TBI trial—a commentary
  1. Joanna L C Wheble and
  2. D K Menon
  1. Department of Anaesthesia, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
  1. Correspondence to Wg Cdr Joanna Wheble, Department of Anaesthesia, Cambridge University Hospitals NHS Foundation Trust, Hills Road, BOX 93, Cambridge CB2 0QQ, UK; joanna.wheble{at}


Each year, approximately 2.5 million people experience some form of traumatic brain injury (TBI) in Europe. One million of these are admitted to hospital and 75 000 will die. TBI represents a major cause of death and disability, particularly among those of working age. Substantial investments have been made in an effort to improve diagnosis, management and survival in TBI, but with little success. The Collaborative European Neuro-Trauma Effectiveness Research in TBI (CENTER-TBI) study promises to use the natural variability seen in the management of TBI across Europe with the application of Comparative Effectiveness Research (CER). It will generate repositories of baseline and comprehensive TBI patient data, neuroimaging, neurogenetics and biomarkers, which aim to improve the diagnosis, stratification, management and prognostication of patients with TBI.

  • Neurogenetics < NEUROLOGY

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.